New options of antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa

scientific article published on 29 July 2014

New options of antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1031099363
P356DOI10.1007/S10096-014-2192-X
P698PubMed publication ID25070493

P2093author name stringI Nakamura
T Yamaguchi
A Sato
S Fukushima
T Matsumoto
A Tsukimori
P2860cites workIMP-12, a new plasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolateQ34939154
Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infectionsQ36095874
Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli.Q39470560
Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.Q43225854
In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosaQ44636897
Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.Q45981762
Effectiveness of antibiotic combination therapy as evaluated by the Break-point Checkerboard Plate method for multidrug-resistant Pseudomonas aeruginosa in clinical use.Q50726914
The fractional inhibitory concentration (FIC) index as a measure of synergyQ71796362
Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureusQ73328444
Use of Parenteral Colistin for the Treatment of Serious Infection Due to Antimicrobial-Resistant Pseudomonas aeruginosaQ79291069
In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in JapanQ83317700
'Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosaQ83366970
P433issue1
P921main subjectPseudomonas aeruginosaQ31856
multiple drug resistanceQ643839
P304page(s)83-87
P577publication date2014-07-29
P1433published inEuropean Journal of Clinical Microbiology & Infectious DiseasesQ15754378
P1476titleNew options of antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa
P478volume34

Reverse relations

cites work (P2860)
Q40675239Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia
Q26751041Clinical Usefulness of Arbekacin
Q36409828Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa
Q41240109In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.
Q40412684Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections.

Search more.